6-Fluoro-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid hydrochloride, 97%, 10g

Butyric acid, min. 99%, for synthesis, 1L, glass packaging

4-((1S,2S,5R)-2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclohexyl)morpholine 4-oxide, 98%, 250mg

Ethyl 2,4-dimethylthiazole-5-carboxylate, 97.0%, 1g

exo-3-Fluoro-8-azabicyclo[3.2.1]octane hydrochloride, 98%, 100mg

Methyl Pyrimidine-2-carboxylate, 97.0%, 100g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)dec-9-enoic acid, 97%, 250mg

Nitrilotriacetic acid (trisodium salt monohydrate), 97%, 10g

3-Nitrophthalic Acid>98.0%(HPLC)(T)500g

1-Cyclopentyloxy-3-nitrobenzene, 97%, 1g

2-Fluoro-6-iodophenol, 95.0%, 10g

4-(4-Aminophenyl)tetrahydro-2H-pyran-4-carbonitrile, 97%, 1g

5-Ethynyl-1-methyl-1H-imidazole, 95.0%, 100mg